eMedAsia and CLEA Collaborates for Provision of Virtual COVID Screening

Hong Seng announced today that its subsidiary eMedAsia has further expanded its agreement with CLEA Technology Sdn Bhd (CLEA) in relation to the exclusive collaboration for provision of Virtual Covid-19 Screening.

eMedAsia and CLEA expressed their intention to expand on the services and conveniences offered to the Ministry of Health Malaysia and other authorities involved in involved in the opening of the country’s borders in the detailed agreement.

Both parties are desirous in collaborating with each other to provide Covid-19 Professional RTK-Antigen testing via CLEADOC Virtual Screening’s in-app methodology which are in compliance with MoH’s requirements and guidelines, supervised by a panel doctor from CLEADOC’s panel listing, following the government’s latest protocol with regards to the requirements and SOP for Virtual RTK Antigen testing as an alternative Covid-19 screening method.

“In addition to our recent Collaboration Agreement with CLEA, both parties have agreed to further expand its range of offerings in order to facilitate a successful border reopening for Malaysia. We have agreed to share all revenue on a 50:50 basis,” KOOP MMA Chairman & eMedAsia Director Dr. Thirunavukarasu Rajoo explained.

Under the latest agreement, CLEADOC will also be onboarding more clinics and doctors to
participate in the services arising from the testing, provide support services as required by the relevant authorities, as well as ensure all infrastructure, support or any other features including the service levels shall conform to the authorities’ requirements including any changes from time to time.

To recap, eMedAsia entered into an exclusive partnership with CLEA on 6 April 2022; the first company that provides CLEADOC Virtual Covid-19 Professional RTK and PCR Screenings
(VCS) and other related services in Malaysia.

Through the partnership which involves exclusive backend system integrations, eMedAsia, a 60%-owned subsidiary under the Group’s healthcare arm HS Bio Group in partnership with Koperasi Persatuan Perubatan Malaysia (KOOP MMA) which is in turn the investment arm of the MMA (Malaysia Medical Assocation) will be able to provide CLEADOC VCS services to both the inbound and outbound travellers as preparation for the next phase of border reopening.

Previous articleLargest Physical Retail Merchant Coverage
Next articleBactakleen Partners SEERS To Promote Post COVID-19 Healing


Please enter your comment!
Please enter your name here